Inovio Pharmaceuticals Inc. (INO)

Trade INO now with
6/27/2022 8:02:26 AM INOVIO Appoints Michael Sumner As Chief Medical Officer
5/27/2022 8:03:55 AM INOVIO Announces Survival Results For INO-5401 + INO-9012 In With Libtayo In Patients With Newly Diagnosed GBM At ASCO
5/10/2022 4:15:42 PM INOVIO Reports Q1 Loss Per Share Of $0.36 Vs. $0.27 Last Year
5/10/2022 4:14:36 PM INOVIO Appoints Jacqueline Shea As CEO
3/24/2022 3:01:02 AM Geneos Therapeutics Secures $17 Mln In Series A2 Financing To Advance Personalized Cancer Immunotherapy Platform
3/1/2022 4:17:26 PM INOVIO Q4 Loss/share $0.50 Vs. Loss $0.14 Year Ago
12/14/2021 8:07:45 AM INOVIO Highlights Updates On Phase 3 Program For VGX-3100, DNA-based Immunotherapy For Treatment Of Cervical HSIL
11/30/2021 8:06:52 AM INOVIO Says Initiated Pre-clinical Development Of Omicron-specific DNA Vaccine Candidate
11/16/2021 8:04:24 AM INOVIO Collaborates With Geneva University Hospitals For Heterologous Booster Trial Of Ebola DNA Vaccine Candidate